Xue‐Yong Zhu

机构：Wuhan University, Renmin Hospital of Wuhan University · ORCID：0000-0002-0530-3006

发表论文 43 篇 · 总被引 2614 次 · h-index 30

代表论文

• An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury (2017 · Nature Medicine · 被引 242)
• Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates (2017 · Nature Medicine · 被引 222)
• The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis (2017 · Nature Medicine · 被引 191)
• Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4 (2017 · Nature Medicine · 被引 154)
• The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis (2018 · Nature Medicine · 被引 150)
• Ubiquitin‐Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6 (2018 · Hepatology · 被引 125)